A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

NCT02920242 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to low enrollment

Conditions

Travelers' Diarrhea

Interventions

DRUG: Rifaximin (Sandoz GmbH) tablet
DRUG: Rifaximin (Xifaxan)
DRUG: Placebo

Sponsor

Sandoz